Maybe this is the answer
Treatment with PBT-2 significantly improved behavioural deficits, biochemical profiles, cellular damage, and curbed the deposition of APP in zinc-induced senescent mice. These findings suggest that PBT-2, acting as a metal-protein attenuating compound, may be helpful in the prevention of AD or alleviation of ageing.
http://link.springer.com/article/10.1007/s10534-016-9922-8
Less and less sellers, page-10
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.6¢ |
Change
0.001(9.09%) |
Mkt cap ! $31.92M | |||
| Open | High | Low | Value | Volume |
| 0.6¢ | 0.6¢ | 0.6¢ | $34.68K | 5.791M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 46 | 25099698 | 0.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.6¢ | 1101214 | 3 |
View Market Depth
| Last trade - 16.10pm 23/12/2024 (20 minute delay) ? |
| ATH (ASX) Chart |
